MedTrace Logo

Pedialyte or Gatorade for Viral Gastroenteritis in Adults: a Randomized, Controlled Trial

NCT00257374 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL

Last updated 2014-01-09

No results posted yet for this study

Summary

Background: Pedialyte and Gatorade are advocated for the treatment of dehydration in viral gastroenteritis, but there is limited evidence to support their use.

Objective: To examine the efficacy, safety and palatability of Pedialyte, Gatorade, and a New Oral Rehydration Solution (NS).

Design: Randomized double blind. Setting: Inpatient, community hospital. Patients/Interventions: 75 consecutive adult patients (m/f=44/33) admitted with viral gastroenteritis were randomized to receive Gatorade, Pedialyte or NS for 48 hours. A yogurt/rice diet was allowed ad libitum.

Measurements: Stool and urine output, electrolytes, fluid intake, body weight, hematocrit and palatability of solutions.

Limitations: Smaller sample size and higher drop out (20%).

Conditions

Interventions

DRUG

Gatorade, Pedialyte and New Solution

Sponsors & Collaborators

  • Augusta University

    lead OTHER

Principal Investigators

  • Satish SC Rao, MD,PhD, FRCP(LON) · University of Iowa

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Countries

  • India

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00257374 on ClinicalTrials.gov